Heck Capital Advisors LLC Invests $1.65 Million in UnitedHealth Group Incorporated (NYSE:UNH)

Heck Capital Advisors LLC acquired a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 3,260 shares of the healthcare conglomerate’s stock, valued at approximately $1,649,000.

Other hedge funds have also made changes to their positions in the company. Quarry LP boosted its holdings in shares of UnitedHealth Group by 132.1% in the second quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock valued at $33,000 after acquiring an additional 37 shares in the last quarter. AMF Tjanstepension AB increased its position in UnitedHealth Group by 88.0% during the 3rd quarter. AMF Tjanstepension AB now owns 258,833 shares of the healthcare conglomerate’s stock worth $151,374,000 after purchasing an additional 121,180 shares during the period. Czech National Bank boosted its stake in shares of UnitedHealth Group by 7.3% in the third quarter. Czech National Bank now owns 188,110 shares of the healthcare conglomerate’s stock valued at $109,984,000 after buying an additional 12,721 shares in the last quarter. Unique Wealth LLC raised its position in UnitedHealth Group by 6.0% in the third quarter. Unique Wealth LLC now owns 3,427 shares of the healthcare conglomerate’s stock worth $2,003,000 after acquiring an additional 194 shares in the last quarter. Finally, Wiser Wealth Management Inc purchased a new stake in shares of UnitedHealth Group during the 3rd quarter worth $246,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on the stock. Stephens upped their target price on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research report on Thursday, December 5th. TD Cowen lifted their price objective on UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a report on Friday, October 18th. Hsbc Global Res upgraded UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. Oppenheimer increased their price objective on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. Finally, Morgan Stanley lowered their price target on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 16th. One analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Buy” and a consensus target price of $629.32.

UnitedHealth Group Price Performance

UNH opened at $542.30 on Friday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The stock has a market capitalization of $499.07 billion, a PE ratio of 34.99, a P/E/G ratio of 1.46 and a beta of 0.62. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The company’s 50 day simple moving average is $537.14 and its 200 day simple moving average is $564.96.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business’s quarterly revenue was up 6.8% on a year-over-year basis. During the same period last year, the company posted $5.83 EPS. As a group, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.64 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were given a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.55%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s payout ratio is currently 54.19%.

Insider Activity at UnitedHealth Group

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the firm’s stock in a transaction on Friday, January 17th. The stock was purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares in the company, valued at $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 0.33% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.